GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

Research

Photo for MIPAD

MIPAD

Official Title

Myocardial infarction prescription adherence duration study: MIPAD

Status

Ongoing

Overview

To reduce the morbidity and mortality of post-myocardial infarction (MI) patients through improved long-term cardiac medication adherence. The specific objectives are to: (1) assess the impact on long-term cardiac medication adherence following the implementation of standardized process to increase in discharge prescription length to 90 days with 3 repeats in post-MI patients as compared to usual care; (2) assess the cost implications of this new strategy as compared to usual care; (3) compare clinical outcomes between longer (>60 days) versus shorter prescription durations; (4) collect baseline information to inform a multi-centre interventional study (i.e. simple monthly proportions of 1-year adherence by hospitals in Ontario).

Study Design

Quasi-experimental, controlled interrupted time series design

Primary Endpoint

Increased proportion of patients with high adherence (proportion of days covered (PDC) >80%) for the combined four cardiac medications classes at one year.

Number of Patients

8000

Number of Sites

3

Number of Countries

1

Study Period

2017-2019

Principal Investigator

J-D Schwalm, Noah Ivers

Program Manager

Tara McCready

Research Coordinator

Dawn Ashforth, Erin O’Brien